Pept??deos de defesa do hospedeiro como adjuvantes na terapia endod??ntica
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Tipo de documento: | Tese |
Idioma: | por |
Título da fonte: | Biblioteca Digital de Teses e Dissertações da UCB |
Texto Completo: | https://bdtd.ucb.br:8443/jspui/handle/tede/2474 |
Resumo: | Failure of endodontic therapy is mainly based on the persistence of the microorganism inside the root canal system, perpetuating periradicular pathologies. The need for endodontic reintervention reduces the success rate and turns the development of new therapies into a necessity. Host defense peptides (HDPs) have a therapeutic potential because of its characteristics as broad spectrum antimicrobial activity, immunomodulatory capacity and repair induction. The present study aimed to demonstrate HDPs HHC-10, LL-37 and synoeca-MP activities compared to the commonly used chemical agents Ca(OH)2, NaOCl and chlorhexidine (CHX) in in vitro and in vivo environments. In vitro analysis involved (1) antimicrobial assays for MIC/MBC/MFC determination, antibiofilm and synergistic activities (against Candida albicans, Enterococcus faecalis and Staphylococcus aureus), (2) hemolytic assay and determination of therapeutic index, (3) immunomodulation assays (from RAW 264.7 monocytes) and (4) osteoclastogenesis assays (from mouse bone marrow cells). In vivo assays were based on periradicular lesions induced and treated in rats with subsequent analysis by radiographic, tomographic and histological examinations. Results demonstrated effective antimicrobial activity of HHC-10 (except antibiofilm activity) and synoeca-MP besides NaOCl and CHX. Higher therapeutic index was observed for peptides (HHC-10 and synoeca-MP) with low or no hemolytic activity. Synergism analysis demonstrated better interaction between synoeca-MP and CHX. Immune assays from monocyte cultures demonstrated a pro-inflammatory activity of LL-37 and synoeca-MP and a pro- and anti-inflammatory effect of HHC-10 and Ca(OH)2. However, none of the agents tested reduced osteoclastogenesis in vitro. In in vivo endodontic treatment conditions, HHC-10, synoeca-MP and Ca(OH)2 significantly reduced periapical lesions, although only peptides were able to reduce inflammation in histological analysis. Therefore, HHC-10 and synoeca-MP demonstrated in vitro and in vivo potential for application in endodontic therapy. However, further researches are needed regarding the mechanism of action of HDPs and the possible therapeutic formulations for future analysis in animal models. |
id |
UCB_7bfb3243f54cc0b96f8de7b18355d5ae |
---|---|
oai_identifier_str |
oai:bdtd.ucb.br:tede/2474 |
network_acronym_str |
UCB |
network_name_str |
Biblioteca Digital de Teses e Dissertações da UCB |
spelling |
Rezende, Taia Maria Bertohttp://lattes.cnpq.br/2108543063213963http://lattes.cnpq.br/5232734207402542Lima, Stella Maris de Freitas2018-11-07T17:53:52Z2018-08-21LIMA, Stella Maris de Freitas. Pept??deos de defesa do hospedeiro como adjuvantes na terapia endod??ntica. 2018. 148 f. Tese (Programa Stricto Sensu em Ci??ncias Gen??micas e Biotecnologia) - Universidade Cat??lica de Bras??lia, Bras??lia, 2018.https://bdtd.ucb.br:8443/jspui/handle/tede/2474Failure of endodontic therapy is mainly based on the persistence of the microorganism inside the root canal system, perpetuating periradicular pathologies. The need for endodontic reintervention reduces the success rate and turns the development of new therapies into a necessity. Host defense peptides (HDPs) have a therapeutic potential because of its characteristics as broad spectrum antimicrobial activity, immunomodulatory capacity and repair induction. The present study aimed to demonstrate HDPs HHC-10, LL-37 and synoeca-MP activities compared to the commonly used chemical agents Ca(OH)2, NaOCl and chlorhexidine (CHX) in in vitro and in vivo environments. In vitro analysis involved (1) antimicrobial assays for MIC/MBC/MFC determination, antibiofilm and synergistic activities (against Candida albicans, Enterococcus faecalis and Staphylococcus aureus), (2) hemolytic assay and determination of therapeutic index, (3) immunomodulation assays (from RAW 264.7 monocytes) and (4) osteoclastogenesis assays (from mouse bone marrow cells). In vivo assays were based on periradicular lesions induced and treated in rats with subsequent analysis by radiographic, tomographic and histological examinations. Results demonstrated effective antimicrobial activity of HHC-10 (except antibiofilm activity) and synoeca-MP besides NaOCl and CHX. Higher therapeutic index was observed for peptides (HHC-10 and synoeca-MP) with low or no hemolytic activity. Synergism analysis demonstrated better interaction between synoeca-MP and CHX. Immune assays from monocyte cultures demonstrated a pro-inflammatory activity of LL-37 and synoeca-MP and a pro- and anti-inflammatory effect of HHC-10 and Ca(OH)2. However, none of the agents tested reduced osteoclastogenesis in vitro. In in vivo endodontic treatment conditions, HHC-10, synoeca-MP and Ca(OH)2 significantly reduced periapical lesions, although only peptides were able to reduce inflammation in histological analysis. Therefore, HHC-10 and synoeca-MP demonstrated in vitro and in vivo potential for application in endodontic therapy. However, further researches are needed regarding the mechanism of action of HDPs and the possible therapeutic formulations for future analysis in animal models.O insucesso da terapia endod??ntica est?? baseado na persist??ncia de microrganismos principalmente no interior do sistema de canais radiculares, perpetuando as patologias perirradiculares associadas ?? tal infec????o. A necessidade de reinterven????o endod??ntica reduz o percentual de sucesso e, portanto, o surgimento de novas terapias ?? necess??rio. Dessa forma, pept??deos de defesa do hospedeiro (PDHs) possuem potencial terap??utico associado ??s suas caracter??sticas de atividade antimicrobiana de amplo espectro, capacidade imunomodulat??ria e indu????o de reparo. O presente estudo objetivou demonstrar a atividade dos PDHs HHC-10, LL-37 e synoeca-MP comparado aos agentes qu??micos comumente utilizados Ca(OH)2, NaOCl e clorexidina (CHX) em ambientes in vitro e in vivo. Para tanto, foram realizadas an??lises in vitro envolvendo: (1) ensaios antimicrobianos com determina????o de MIC/MBC/MFC, atividade antibiofilme e atividade sin??rgica (contra Candida albicans, Enterococcus faecalis e Staphylococcus aureus), (2) ensaio hemol??tico e determina????o do ??ndice terap??utico, (3) ensaios de imunomodula????o (a partir de mon??citos RAW 264.7) e (4) ensaios osteoclastog??nese (a partir de c??lulas da medula ??ssea de camundongos). Os ensaios in vivo foram conduzidos a partir das les??es perirradiculares induzidas e tratadas em ratos com subsequente an??lise por exames radiogr??ficos, tomogr??ficos e histol??gicos. Assim, os resultados demonstraram efetiva atividade antimicrobiana dos pept??deos HHC-10 (exceto atividade antibiofilme) e synoeca-MP al??m do NaOCl e CHX. Observou-se maiores ??ndices terap??uticos para os pept??deos (HHC-10 e synoeca-MP) com baixa ou nenhuma atividade hemol??tica. As an??lises de intera????o demonstraram combina????o sin??rgica necessitando de menor concentra????o a partir da intera????o entre synoeca-MP e CHX. A partir da cultura de mon??citos, observou-se uma atividade pr??-inflamat??ria a partir dos pept??deos LL-37 e synoeca-MP e um efeito pr??- e anti-inflamat??rio do pept??deo HHC-10 e do Ca(OH)2. No entanto, nenhum dos agentes testados reduziram a osteoclastog??nese in vitro. J?? em condi????es de tratamento endod??ntico in vivo, os PDHs HHC-10, synoeca-MP e o Ca(OH)2 reduziram significativamente les??es periapicais, apesar de somente os pept??deos serem capazes de reduzir inflama????o em an??lises histol??gicas. Portanto, os pept??deos HHC-10 e synoeca-MP demonstraram potencial in vitro e in vivo para aplica????o na terapia endod??ntica. No entanto, faz-se necess??rio maiores investiga????es sobre o mecanismo de a????o dos mesmos e poss??veis formula????es terap??uticas para futuros testes em modelos animais.Submitted by Sara Ribeiro (sara.ribeiro@ucb.br) on 2018-11-07T17:53:28Z No. of bitstreams: 1 StellaMarisdeFreitasLimaTese2018.pdf: 12066835 bytes, checksum: 9ad384b4f040333154c3598b59852583 (MD5)Approved for entry into archive by Sara Ribeiro (sara.ribeiro@ucb.br) on 2018-11-07T17:53:52Z (GMT) No. of bitstreams: 1 StellaMarisdeFreitasLimaTese2018.pdf: 12066835 bytes, checksum: 9ad384b4f040333154c3598b59852583 (MD5)Made available in DSpace on 2018-11-07T17:53:52Z (GMT). No. of bitstreams: 1 StellaMarisdeFreitasLimaTese2018.pdf: 12066835 bytes, checksum: 9ad384b4f040333154c3598b59852583 (MD5) Previous issue date: 2018-08-21application/pdfhttps://bdtd.ucb.br:8443/jspui/retrieve/5980/StellaMarisdeFreitasLimaTese2018.pdf.jpgporUniversidade Cat??lica de Bras??liaPrograma Stricto Sensu em Ci??ncias Gen??micas e BiotecnologiaUCBBrasilEscola de Sa??de e MedicinaEndodontiaMedica????o intracanalPept??deos antimicrobianosPept??deos de defesa do hospedeiroHost defense peptidesAntimicrobial peptidesIntracanal dressingEndodonticsCNPQ::CIENCIAS BIOLOGICASPept??deos de defesa do hospedeiro como adjuvantes na terapia endod??nticainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisinfo:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da UCBinstname:Universidade Católica de Brasília (UCB)instacron:UCBLICENSElicense.txtlicense.txttext/plain; charset=utf-81831https://200.214.135.178:8443/jspui/bitstream/tede/2474/1/license.txtd7d5e5ec75089f122abe937645a56120MD51ORIGINALStellaMarisdeFreitasLimaTese2018.pdfStellaMarisdeFreitasLimaTese2018.pdfapplication/pdf12066835https://200.214.135.178:8443/jspui/bitstream/tede/2474/2/StellaMarisdeFreitasLimaTese2018.pdf9ad384b4f040333154c3598b59852583MD52TEXTStellaMarisdeFreitasLimaTese2018.pdf.txtStellaMarisdeFreitasLimaTese2018.pdf.txttext/plain246924https://200.214.135.178:8443/jspui/bitstream/tede/2474/3/StellaMarisdeFreitasLimaTese2018.pdf.txt96afa666dbe7a53718365c2cce96351eMD53THUMBNAILStellaMarisdeFreitasLimaTese2018.pdf.jpgStellaMarisdeFreitasLimaTese2018.pdf.jpgimage/jpeg5508https://200.214.135.178:8443/jspui/bitstream/tede/2474/4/StellaMarisdeFreitasLimaTese2018.pdf.jpg773641351a78d90e4d63ea951e3036b2MD54tede/24742018-11-08 01:11:38.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Biblioteca Digital de Teses e Dissertaçõeshttps://bdtd.ucb.br:8443/jspui/ |
dc.title.por.fl_str_mv |
Pept??deos de defesa do hospedeiro como adjuvantes na terapia endod??ntica |
title |
Pept??deos de defesa do hospedeiro como adjuvantes na terapia endod??ntica |
spellingShingle |
Pept??deos de defesa do hospedeiro como adjuvantes na terapia endod??ntica Lima, Stella Maris de Freitas Endodontia Medica????o intracanal Pept??deos antimicrobianos Pept??deos de defesa do hospedeiro Host defense peptides Antimicrobial peptides Intracanal dressing Endodontics CNPQ::CIENCIAS BIOLOGICAS |
title_short |
Pept??deos de defesa do hospedeiro como adjuvantes na terapia endod??ntica |
title_full |
Pept??deos de defesa do hospedeiro como adjuvantes na terapia endod??ntica |
title_fullStr |
Pept??deos de defesa do hospedeiro como adjuvantes na terapia endod??ntica |
title_full_unstemmed |
Pept??deos de defesa do hospedeiro como adjuvantes na terapia endod??ntica |
title_sort |
Pept??deos de defesa do hospedeiro como adjuvantes na terapia endod??ntica |
author |
Lima, Stella Maris de Freitas |
author_facet |
Lima, Stella Maris de Freitas |
author_role |
author |
dc.contributor.advisor1.fl_str_mv |
Rezende, Taia Maria Berto |
dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/2108543063213963 |
dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/5232734207402542 |
dc.contributor.author.fl_str_mv |
Lima, Stella Maris de Freitas |
contributor_str_mv |
Rezende, Taia Maria Berto |
dc.subject.por.fl_str_mv |
Endodontia Medica????o intracanal Pept??deos antimicrobianos Pept??deos de defesa do hospedeiro |
topic |
Endodontia Medica????o intracanal Pept??deos antimicrobianos Pept??deos de defesa do hospedeiro Host defense peptides Antimicrobial peptides Intracanal dressing Endodontics CNPQ::CIENCIAS BIOLOGICAS |
dc.subject.eng.fl_str_mv |
Host defense peptides Antimicrobial peptides Intracanal dressing Endodontics |
dc.subject.cnpq.fl_str_mv |
CNPQ::CIENCIAS BIOLOGICAS |
dc.description.abstract.eng.fl_txt_mv |
Failure of endodontic therapy is mainly based on the persistence of the microorganism inside the root canal system, perpetuating periradicular pathologies. The need for endodontic reintervention reduces the success rate and turns the development of new therapies into a necessity. Host defense peptides (HDPs) have a therapeutic potential because of its characteristics as broad spectrum antimicrobial activity, immunomodulatory capacity and repair induction. The present study aimed to demonstrate HDPs HHC-10, LL-37 and synoeca-MP activities compared to the commonly used chemical agents Ca(OH)2, NaOCl and chlorhexidine (CHX) in in vitro and in vivo environments. In vitro analysis involved (1) antimicrobial assays for MIC/MBC/MFC determination, antibiofilm and synergistic activities (against Candida albicans, Enterococcus faecalis and Staphylococcus aureus), (2) hemolytic assay and determination of therapeutic index, (3) immunomodulation assays (from RAW 264.7 monocytes) and (4) osteoclastogenesis assays (from mouse bone marrow cells). In vivo assays were based on periradicular lesions induced and treated in rats with subsequent analysis by radiographic, tomographic and histological examinations. Results demonstrated effective antimicrobial activity of HHC-10 (except antibiofilm activity) and synoeca-MP besides NaOCl and CHX. Higher therapeutic index was observed for peptides (HHC-10 and synoeca-MP) with low or no hemolytic activity. Synergism analysis demonstrated better interaction between synoeca-MP and CHX. Immune assays from monocyte cultures demonstrated a pro-inflammatory activity of LL-37 and synoeca-MP and a pro- and anti-inflammatory effect of HHC-10 and Ca(OH)2. However, none of the agents tested reduced osteoclastogenesis in vitro. In in vivo endodontic treatment conditions, HHC-10, synoeca-MP and Ca(OH)2 significantly reduced periapical lesions, although only peptides were able to reduce inflammation in histological analysis. Therefore, HHC-10 and synoeca-MP demonstrated in vitro and in vivo potential for application in endodontic therapy. However, further researches are needed regarding the mechanism of action of HDPs and the possible therapeutic formulations for future analysis in animal models. |
dc.description.abstract.por.fl_txt_mv |
O insucesso da terapia endod??ntica est?? baseado na persist??ncia de microrganismos principalmente no interior do sistema de canais radiculares, perpetuando as patologias perirradiculares associadas ?? tal infec????o. A necessidade de reinterven????o endod??ntica reduz o percentual de sucesso e, portanto, o surgimento de novas terapias ?? necess??rio. Dessa forma, pept??deos de defesa do hospedeiro (PDHs) possuem potencial terap??utico associado ??s suas caracter??sticas de atividade antimicrobiana de amplo espectro, capacidade imunomodulat??ria e indu????o de reparo. O presente estudo objetivou demonstrar a atividade dos PDHs HHC-10, LL-37 e synoeca-MP comparado aos agentes qu??micos comumente utilizados Ca(OH)2, NaOCl e clorexidina (CHX) em ambientes in vitro e in vivo. Para tanto, foram realizadas an??lises in vitro envolvendo: (1) ensaios antimicrobianos com determina????o de MIC/MBC/MFC, atividade antibiofilme e atividade sin??rgica (contra Candida albicans, Enterococcus faecalis e Staphylococcus aureus), (2) ensaio hemol??tico e determina????o do ??ndice terap??utico, (3) ensaios de imunomodula????o (a partir de mon??citos RAW 264.7) e (4) ensaios osteoclastog??nese (a partir de c??lulas da medula ??ssea de camundongos). Os ensaios in vivo foram conduzidos a partir das les??es perirradiculares induzidas e tratadas em ratos com subsequente an??lise por exames radiogr??ficos, tomogr??ficos e histol??gicos. Assim, os resultados demonstraram efetiva atividade antimicrobiana dos pept??deos HHC-10 (exceto atividade antibiofilme) e synoeca-MP al??m do NaOCl e CHX. Observou-se maiores ??ndices terap??uticos para os pept??deos (HHC-10 e synoeca-MP) com baixa ou nenhuma atividade hemol??tica. As an??lises de intera????o demonstraram combina????o sin??rgica necessitando de menor concentra????o a partir da intera????o entre synoeca-MP e CHX. A partir da cultura de mon??citos, observou-se uma atividade pr??-inflamat??ria a partir dos pept??deos LL-37 e synoeca-MP e um efeito pr??- e anti-inflamat??rio do pept??deo HHC-10 e do Ca(OH)2. No entanto, nenhum dos agentes testados reduziram a osteoclastog??nese in vitro. J?? em condi????es de tratamento endod??ntico in vivo, os PDHs HHC-10, synoeca-MP e o Ca(OH)2 reduziram significativamente les??es periapicais, apesar de somente os pept??deos serem capazes de reduzir inflama????o em an??lises histol??gicas. Portanto, os pept??deos HHC-10 e synoeca-MP demonstraram potencial in vitro e in vivo para aplica????o na terapia endod??ntica. No entanto, faz-se necess??rio maiores investiga????es sobre o mecanismo de a????o dos mesmos e poss??veis formula????es terap??uticas para futuros testes em modelos animais. |
description |
Failure of endodontic therapy is mainly based on the persistence of the microorganism inside the root canal system, perpetuating periradicular pathologies. The need for endodontic reintervention reduces the success rate and turns the development of new therapies into a necessity. Host defense peptides (HDPs) have a therapeutic potential because of its characteristics as broad spectrum antimicrobial activity, immunomodulatory capacity and repair induction. The present study aimed to demonstrate HDPs HHC-10, LL-37 and synoeca-MP activities compared to the commonly used chemical agents Ca(OH)2, NaOCl and chlorhexidine (CHX) in in vitro and in vivo environments. In vitro analysis involved (1) antimicrobial assays for MIC/MBC/MFC determination, antibiofilm and synergistic activities (against Candida albicans, Enterococcus faecalis and Staphylococcus aureus), (2) hemolytic assay and determination of therapeutic index, (3) immunomodulation assays (from RAW 264.7 monocytes) and (4) osteoclastogenesis assays (from mouse bone marrow cells). In vivo assays were based on periradicular lesions induced and treated in rats with subsequent analysis by radiographic, tomographic and histological examinations. Results demonstrated effective antimicrobial activity of HHC-10 (except antibiofilm activity) and synoeca-MP besides NaOCl and CHX. Higher therapeutic index was observed for peptides (HHC-10 and synoeca-MP) with low or no hemolytic activity. Synergism analysis demonstrated better interaction between synoeca-MP and CHX. Immune assays from monocyte cultures demonstrated a pro-inflammatory activity of LL-37 and synoeca-MP and a pro- and anti-inflammatory effect of HHC-10 and Ca(OH)2. However, none of the agents tested reduced osteoclastogenesis in vitro. In in vivo endodontic treatment conditions, HHC-10, synoeca-MP and Ca(OH)2 significantly reduced periapical lesions, although only peptides were able to reduce inflammation in histological analysis. Therefore, HHC-10 and synoeca-MP demonstrated in vitro and in vivo potential for application in endodontic therapy. However, further researches are needed regarding the mechanism of action of HDPs and the possible therapeutic formulations for future analysis in animal models. |
publishDate |
2018 |
dc.date.accessioned.fl_str_mv |
2018-11-07T17:53:52Z |
dc.date.issued.fl_str_mv |
2018-08-21 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/doctoralThesis |
status_str |
publishedVersion |
format |
doctoralThesis |
dc.identifier.citation.fl_str_mv |
LIMA, Stella Maris de Freitas. Pept??deos de defesa do hospedeiro como adjuvantes na terapia endod??ntica. 2018. 148 f. Tese (Programa Stricto Sensu em Ci??ncias Gen??micas e Biotecnologia) - Universidade Cat??lica de Bras??lia, Bras??lia, 2018. |
dc.identifier.uri.fl_str_mv |
https://bdtd.ucb.br:8443/jspui/handle/tede/2474 |
identifier_str_mv |
LIMA, Stella Maris de Freitas. Pept??deos de defesa do hospedeiro como adjuvantes na terapia endod??ntica. 2018. 148 f. Tese (Programa Stricto Sensu em Ci??ncias Gen??micas e Biotecnologia) - Universidade Cat??lica de Bras??lia, Bras??lia, 2018. |
url |
https://bdtd.ucb.br:8443/jspui/handle/tede/2474 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Cat??lica de Bras??lia |
dc.publisher.program.fl_str_mv |
Programa Stricto Sensu em Ci??ncias Gen??micas e Biotecnologia |
dc.publisher.initials.fl_str_mv |
UCB |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
Escola de Sa??de e Medicina |
publisher.none.fl_str_mv |
Universidade Cat??lica de Bras??lia |
dc.source.none.fl_str_mv |
reponame:Biblioteca Digital de Teses e Dissertações da UCB instname:Universidade Católica de Brasília (UCB) instacron:UCB |
instname_str |
Universidade Católica de Brasília (UCB) |
instacron_str |
UCB |
institution |
UCB |
reponame_str |
Biblioteca Digital de Teses e Dissertações da UCB |
collection |
Biblioteca Digital de Teses e Dissertações da UCB |
bitstream.url.fl_str_mv |
https://200.214.135.178:8443/jspui/bitstream/tede/2474/1/license.txt https://200.214.135.178:8443/jspui/bitstream/tede/2474/2/StellaMarisdeFreitasLimaTese2018.pdf https://200.214.135.178:8443/jspui/bitstream/tede/2474/3/StellaMarisdeFreitasLimaTese2018.pdf.txt https://200.214.135.178:8443/jspui/bitstream/tede/2474/4/StellaMarisdeFreitasLimaTese2018.pdf.jpg |
bitstream.checksum.fl_str_mv |
d7d5e5ec75089f122abe937645a56120 9ad384b4f040333154c3598b59852583 96afa666dbe7a53718365c2cce96351e 773641351a78d90e4d63ea951e3036b2 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1724829778374033408 |